Igm anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the nordic diltiazem (nordil) study and the integrated imaging and biomarker study 3 (ibis-3)

HIGHLIGHTS

• who: Necrotic core et al. from the Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands Department of Clinical Sciences, Malmö, Lund University, Clinical Research Center, Malmö, Sweden have published the research work: IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3), in the Journal: (JOURNAL)
• what: The authors report herein that individuals with low IgM anti-MDA-LDL antibody levels, and to a lesser extent levels of total serum IgM, are significantly . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.